BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25452439)

  • 1. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.
    Frazier AL; Hale JP; Rodriguez-Galindo C; Dang H; Olson T; Murray MJ; Amatruda JF; Thornton C; Arul GS; Billmire D; Shaikh F; Pashankar F; Stoneham S; Krailo M; Nicholson JC
    J Clin Oncol; 2015 Jan; 33(2):195-201. PubMed ID: 25452439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian Yolk Sac Tumors; Does Age Matter?
    Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
    Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic features of human chorionic gonadotropin- or alpha-fetoprotein-producing germ cell tumors of the central nervous system: histological heterogeneity and surgical meaning.
    Sugiyama K; Arita K; Tominaga A; Hanaya R; Taniguchi E; Okamura T; Itoh Y; Yamasaki F; Kurisu K
    Brain Tumor Pathol; 2001; 18(2):115-22. PubMed ID: 11908867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
    Calaminus G; Schneider DT; Bökkerink JP; Gadner H; Harms D; Willers R; Göbel U
    J Clin Oncol; 2003 Mar; 21(5):781-6. PubMed ID: 12610174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
    Moran CA; Suster S; Koss MN
    Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study.
    Marina N; London WB; Frazier AL; Lauer S; Rescorla F; Cushing B; Malogolowkin MH; Castleberry RP; Womer RB; Olson T
    J Clin Oncol; 2006 Jun; 24(16):2544-8. PubMed ID: 16735707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in children with localized malignant nonseminomatous germ cell tumors.
    Baranzelli MC; Kramar A; Bouffet E; Quintana E; Rubie H; Edan C; Patte C
    J Clin Oncol; 1999 Apr; 17(4):1212. PubMed ID: 10561181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical analysis of management of pediatric testicular germ cell tumors.
    Ye YL; Sun XZ; Zheng FF; Bian J; Huang YP; Zhang XQ; Li ZX; Nie Y; Qin ZK; Dai YP
    Urology; 2012 Apr; 79(4):892-7. PubMed ID: 22305424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
    Fresneau B; Orbach D; Faure-Conter C; Sudour-Bonnange H; Vérité C; Gandemer V; Pasquet M; Fasola S; Rome A; Raimbault S; Martelli H; Frappaz D; Le Teuff G; Patte C
    Eur J Cancer; 2018 May; 95():11-19. PubMed ID: 29604495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of extracranial malignant germ cell tumours in two age groups of children (0-10 and 10-18 years). Multicentre experiences].
    Drozyńska E; Połczyńska K; Popadiuk S; Niedzwiecki M; Wiśniewski J; Balcerska A; Izycka-Swieszewska E; Bilska K; Balwierz W; Chełmecka L; Chybicka A; Dudeńko I; Karolczyk G; Kowalczyk J; Krawczuk-Rybak M; Kurylak A; Leszczyńska E; Matysiak M; Młynarski W; Pobudejska A; Sobol G; Sońta-Jakimczyk D; Szajdak K; Tredowska-Skoczeń D; Szmyd K; Trelińska J; Urasiński T; Wachowiak J; Wieczorek M; Wiśniewska-Slusarz H; Woźniak S; Woźniak W; Wysocki M
    Med Wieku Rozwoj; 2011; 15(1):16-24. PubMed ID: 21786508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surgical management in pediatric germ cell tumors (GCTs), NCI case series.
    Fakhr IM; Khalil el-SA; El-Baradie TS; Shaalan MA; Shalaby LM; Nassif SL; Farahat IG
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):70-9. PubMed ID: 19847284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical resection and outcome of malignant ovarian germ cell tumors in children-a national multicentric study compared to international results.
    Elgendy A; Mostafa M; Salem MA; Ali A; Khairi A; Shehata S
    Pediatr Surg Int; 2020 Sep; 36(9):1067-1075. PubMed ID: 32681191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in children with extracranial malignant germ cell tumors: a monocentric pediatric Tunisian study.
    Fedhila F; Rhayem S; Hafsi H; Douira W; Doghri R; Khemiri M; Mrad K; Bellagha I; Zouari B; Barsaoui S
    Tunis Med; 2016 Apr; 94(4):309-314. PubMed ID: 27704516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors.
    De Backer A; Madern GC; Pieters R; Haentjens P; Hakvoort-Cammel FG; Oosterhuis JW; Hazebroek FW
    Eur J Pediatr Surg; 2008 Feb; 18(1):1-6. PubMed ID: 18302061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
    Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
    J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of clinical-pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors.
    Bonet AS; Muñoz-Delgado EG; Vico FJ; Ruiz JC; Chapado MS
    Arch Esp Urol; 2011 Dec; 64(10):972-80. PubMed ID: 22228895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors].
    Calaminus G; Vesterling-Hörner D; Bökkerink JP; Gadner H; Günther G; Haas HJ; Jürgens H; Teske C; Göbel U
    Klin Padiatr; 1991; 203(4):246-50. PubMed ID: 1719268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant germ cell tumours. Multicenter prospective trial in Polish Pediatric Group for Solid Tumours (years 1998-2000)].
    Popadiuk S; Korzon M; Szumera M; Chybicka A; Szmyd K; Dzierzega M; Kowalczyk JR; Wiśniewska-Slusarz H; Trelińska J; Wozniak W; Bilska K; Wysocki M; Krawczuk-Rybak M; Lopatka B
    Przegl Lek; 2004; 61 Suppl 2():29-32. PubMed ID: 15686043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPCAM-A novel molecular target for the treatment of pediatric and adult germ cell tumors.
    Schönberger S; Okpanyi V; Calaminus G; Heikaus S; Leuschner I; Nicholson JC; Stoecklein NH; Schneider DT; Borkhardt A
    Genes Chromosomes Cancer; 2013 Jan; 52(1):24-32. PubMed ID: 22987628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.